All the Therapeutic System Drugs
Estrogen, Progestogen. Chlormadinone Acetate 2 mg, Ethynilestradiol 0.03 mg. TABS: 1 x 21, 3 x 21. 1 tab. dly for 21 days
foll. by 7 days tab. free. Start on 1st day
of cycle.
Oral contracept.
Estrogen, Progestogen. Ethinylestradiol 0.6 mg, Norelgestromin 6 mg. TRANSDERMAL PATCHES: 3,9. 1st patch on
day 1 of cycle. 1 patch (on same day)/
wk. on day 8 and 15 of cycle. 4th wk
(from day 22) is patch free. New cycle
aft. 7 days patch free. See lit.
Female contraception. Evra is intended for women of fertile age.
Hypersens.
Presence or risk of VTE. Current VTE (on anticoagulants) or history of (e.g. DVT] or PE);Known heredit. or acquir. predisposit. for VT such as: APC-resistan., (includ. Factor V Leiden), antithrombin-III-defic., protein C defic., protein S defic.; Major surg. with prolong. immobilisat.
A high risk of VT due to the presence of multiple risk fact.
Presence /risk of ATE.
Arterial thromboembol. – current ATE , history of ATE (e.g. MI) or prodromal condit. (e.g. angin. p.); Cerebrovasc. dis. – current stroke, history of stroke or prodromal condit. (e.g., TIA); Known heredit. or acquir. predisposit. for ATA such as hyperhomocysteinaemia and APLA. (anticardiolipin-antibodies, lupus anticoagulant); Hist. of migraine with focal neurology. sympt.; A high risk of ATA due to multiple risk fact. or to the presence of one serious risk factor (E.G. diabetes mell. with vascular sympt., sev. hypertens., severe dyslipoproteinaemia.
Known/susp. carcinoma of the breast.
Carcinoma of the endometrium or other known or suspect. oestrogen-depend. neoplasia
Abnorm. liver func. related to acute or chron. hepatocell. dis.
Hepat. adenomas or carcinomas.
Undiagnos. abnorm. gen.bleed.
Concomi. use with the med. products contain. ombitasvir/paritaprevir/ritonavir and dasabuvir.
Estrogen, Progestogen. Desogestrel 0.15 mg, Ethinylestradiol 0.02 mg. TABS. : 1,3,4 (pack) × 21.
1 tab. dly. for 21 days, start. on 1st day of cycle. See lit.
Oral contracept.
C/I: Presence/risk of VTE: current VTE or hist. of DVT or pulmon. embol.,
Known hered./acquired predispos. for VTE., such as APC-resist. (includ. Fact. V Leiden), antithrombin-III-defic., protein C defic., or protein S defic., major surgery with prolong. immobil., high risk of VTE due to the pres. of mult. risk fact. Pres. or risk of arterial thromboem. (ATE): ATE – current ATE or hist. of ATE (e.g. MI) or prodrom. condition (e.g. angina p.)., cerebrovas. dis. – current stroke, hist. of stroke or prodrom. condition (e.g. TIA), known hered. or acquired predispos. for ATE, such as hyperhomocysteinaemia and APLA (anticardiolipin-antibodies, lupus anticoag.); hist. of migraine with focal neurologic. sympt.; high risk of ATE due to mult. risk factors or to pres. of one serious risk factor, such as: diabetes mell. with vasc. sympt.,sev. hypertens., sev. dyslipoproteinaemia.
Pancreat. assoc. with sev. hypertriglyceridem.(current /hist.). Pres. or hist. of sev. hepatic dis., as long as liver funct. has not returned to normal. Pres. or hist. of liver tumours (benign or malignant). Known/suspect. estrogen-dep. tumours. Endometrial hyperplasia. Undiagnosed vag. bleed. Known/ suspect. pregn. Hypersens. to active ingredients or any of excipients. Concom. use with med. products cont. ombitasvir/paritaprevir/ritonavir and dasabuvir. or meds. contain. glecaprevir/pibrentasvir.
See lit.
Estrogen, Progestogen. Ethinylestradiol 0.02 mg, Gestodene 0.075 mg. TABS. 1X21 / 3X21
1 tab. dly for 21 days, foll. by 7 days tab. free. Start on 1st day of cycle. See lit.
Oral contracept.
C/I: Hypersens. to active ingredients or excipients;
presence or risk of ATE – current ATE or hist. of ATE (e.g. MI) or prodrom. condit. (e.g. angina p.). Cerebrovas. dis. – current stroke, hist. of stroke or prodrom. condit. (e.g. TIA), known heredit. or acquired predisposit. for arterial thromboembol., such as hyperhomocysteinaemia and APLA (anticardiolipin-antibodies, lupus anticoag.), hist. of migraine with focal neurologic. sympt., high risk of arterial thromboembol. due to mult. risk factors or to the presence of one ser. risk factor: (e.g. diabetes mell. with vasc. sympt., sev. hypertens., sev. dyslipoproteinaemia), coronary dis.; presence or risk VTE: current VTE (on anticoagul.) or hist. of (e.g DVT, PE), known heredit. or acquir. predisposit. for venous thromboemb., such as APC-resist., (includ. Factor V Leiden), antithrombin-III-defic., protein C defic., protein S defic., major surg. with prolong. immobilizat., high risk of VTE due to the pres. of mult. risk fact.; thrombogenic valvulopathy; thrombogenic arrhythmias; susp. or confirmed breast cancer; susp. or confirmed oestrogen-sensitive neoplasms (endometrial etc.); hepatic adenoma or carcin.; sev. hepatic disord. - until hepatic funct. has normalised;
abnormal vaginal bleed. of unknown cause; susp. or confirmed pregn.; pancreatit. assoc. with sev. hypertriglyceridemia (current or hist.); concom. use with ombitasvir/paritaprevir/ritonavir and dasabuvir or glecaprevir/pibrentasvir or sofosbuvir/velpatasvir/voxilaprevir. See lit
Estrogen, Progestogen. Ethinylestradiol 0.03 mg, Gestodene 0.075 mg. TABS 1/3 x 21.
1 tab. dly. See lit.
Oral Contracept.
C/I: Hypersens. to act. ingred. or any of excipients. Presen. or risk VTE: Thrombophleb. or venous thromboem. – curr. VTE (on anticoagul.) or hist. of (e.g DVT, PE) or other dis., assoc. with an incr. thromboemb. risk such as thrombogen. valvulopathies and thrombogenic rhythm disord. (current / hist.). Known heredit. or acquir. predisposit. for venous thromboemb., such as APC-resistance, (includ. Factor V Leiden), antithrombin-III-defic., protein C defic., protein S defic. Major surg. with prolong. immobiliz. A high risk of VTE due to the presen. of multi. risk fact. Presen. or risk of arterial thromboem. (ATE): ATE – current ATE, hist. of ATE (e.g. MI) or prodrom. condition (e.g. angina p.). Cerebrovasc. or coron. artery dis. – curr. stroke, hist. of stroke or prodrom. condit. (e.g. transient ischaemic attack, TIA). Known hered. or acq. predisposit. for ATE, such as hyperhomocysteinaemia and APLA (anticardiolipin-antibodies, lupus anticoag.). Hist. of migraine with focal neurological sympt. A high risk of ATE due to mult. risk factors or to the pres. of one serious risk factor: (e.g. diabetes mell. with vasc. sympt., sev. hypertens., sev. dyslipoproteinaemia). Known/suspect. carcin. of the breast, carcin. of the endometr. or other known/suspect. estrogen-dependent neoplasia. Undiagn. abnormal vag.bleed. Hepat. adenom./ carcinom., acute /chron. liver dis., as long as liver funct. has not returned to normal. Pancreat. assoc. with severe hypertriglyceridem. (current /history). Known/ suspect. pregn .Concom./use with med. products contain. ombitasvir/paritaprevir/ritonavir and dasabuvir. or meds. contain. glecaprevir/pibrentasvir. See lit.
Estrogen, Progestogen. Ethinylestradiol 0.03 mg, Gestodene 0.075 mg. C. TABS: 1, 3 x 21. 1 tab. dly. for 21 days
start. on 1st day of bleeding. See lit.
Hormonal contracept.
